The prevalence of transgender-related diagnosis codes in the United States increased nearly ninefold from 2014 to 2021, with significant increases in HIV testing and pre-exposure prophylaxis prescriptions in this population, according to a study. The researchers found that the proportion of transgender patients prescribed gender-affirming hormone therapy also rose. Clinicians can use encounters for gender-affirming hormone therapy as opportunities to discuss HIV prevention. The study showed that the trends were primarily driven by those aged 18 to 34 years, and it concluded that health care providers will likely continue to see more patients seeking gender-transitional care and will need to be prepared to provide recommended care.
Source link
PrEP use, HIV testing increased among transgender people from 2014 to 2021
